Breast cancer is a highly heterogenous disease, both at the intra- and inter-tumoral levels, but a major subdivision consists of ER-positive and ER-negative tumors that present, with distinct precursor lesions, clinical behavior, and response to therapies [11,12,13]. This evidence concerns the gene ESR1 and breast cancer.